LG Chem (051910) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
22 Jun, 2026Executive summary
Q1 2026 revenue reached KRW 12.247 trillion, with LG Energy Solution contributing 53.5%, petrochemicals 36.0%, advanced materials 6.6%, life sciences 2.5%, and others 1.4%.
Operating loss was KRW 49.7 billion, with a net loss of KRW 781.9 billion, narrowing from the previous quarter.
Gross margin was 18.9%, but higher SG&A and finance costs led to negative operating and net results.
Total assets stood at KRW 105.7 trillion, liabilities at KRW 57.6 trillion, and equity at KRW 48 trillion.
Market volatility and demand uncertainty persist due to geopolitical risks and weak North American EV demand.
Financial highlights
Q1 consolidated revenue: KRW 12.247 trillion; gross margin: 18.9%; EBITDA: KRW 1,442 billion.
Operating loss: KRW 49.7 billion; net loss: KRW 781.9 billion; basic EPS: -4,449 KRW per share.
Cash and equivalents at quarter-end: KRW 8,532.4 billion.
Positive inventory lagging effects and one-off income from European anti-dumping duty refunds supported petrochemical profitability.
Dividend declared: KRW 2,000 per common share, KRW 2,050 per preferred share.
Outlook and guidance
Petrochemicals expect stable profitability in Q2 despite temporary plant shutdowns, supported by inventory effects and cost controls.
Advanced Materials projected to turn profitable, driven by increased cathode material volumes and new semiconductor materials.
Life Sciences anticipates revenue growth from higher volumes and ongoing global clinical R&D investments.
LG Energy Solution expects revenue growth from expanded ESS shipments and stable cylindrical EV battery demand.
Disciplined CapEx execution under KRW 2 trillion annually, portfolio rebalancing, and asset monetization planned.
Latest events from LG Chem
- Q2 sales rose, but net income and guidance fell amid weak demand and higher costs.051910
Q2 202423 Jun 2026 - Q3 profit rose on Energy Solution gains, but outlook remains cautious amid market headwinds.051910
Q3 202423 Jun 2026 - Q1 2025 saw improved profitability and strong battery sales amid ongoing market volatility.051910
Q1 202523 Jun 2026 - Operating profit improved, but net income was negative amid persistent market headwinds.051910
Q2 202523 Jun 2026 - Q3 2025 profitability rebounded on cost cuts and one-time gains, but outlook stays cautious.051910
Q3 202523 Jun 2026 - Lower 2024 profits and weak demand drive restructuring, cost control, and cautious investment.051910
Q4 202428 May 2026 - Accelerating growth in sustainability, battery materials, and new drugs to drive future value.051910
Corporate presentation20 May 2026 - Four growth drivers are set to triple their revenue share by 2030 through strategic restructuring.051910
Corporate presentation20 May 2026 - Driving global sustainability and innovation with advanced materials and life sciences.051910
Corporate presentation20 May 2026